Document is current
Any future updates will be listed below
-
Authors
Cyr, Brianna https://orcid.org/0000-0002-2924-7416
Vontell, Regina T.
Hadad, Roey
de Rivero Vaccari, Juan Pablo
Keane, Robert W.
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (MJFF-021165, MJFF-021165, MJFF-021165)
- License Information
-
More Information
Article History
Received: 12 August 2024
Accepted: 8 April 2025
First Online: 25 April 2025
Competing interests
: J.P.d.R.V. and R.W.K. are co-founders and managing members of InflamaCORE, LLC, and have licensed patents on inflammasome proteins as biomarkers of injury and disease, as well as on targeting inflammasome proteins for therapeutic purposes. J.P.d.R.V. and R.W.K. are Scientific Advisory Board Members of ZyVersa Therapeutics Inc. ZyVersa Therapeutics holds licensed patents on IC100 as a therapy against inflammasome-related diseases.
